Document:

RESEARCH AND DEVELOPMENT AGREEMENT

 Confidential Treatment has been requested by Constar International Inc. pursuant to Rule 406. All non-public
information has been filed with the Securities and Exchange Commission. 
  
 EXHIBIT 10.8 
  
 Execution Copy 
  
 RESEARCH AND DEVELOPMENT AGREEMENT 
  
 This RESEARCH AND DEVELOPMENT AGREEMENT (this
“Agreement”) is entered into as of November 20, 2002 between CarnaudMetalbox plc, a public limited company formed under the laws of England and Wales (“Carnaud”), Crown Cork & Seal Technologies Corporation
(“Crown Technologies” and, collectively with Carnaud, the “Crown Entities”) and Constar, Inc., a Delaware corporation (“Constar, Inc.”). 
  
 BACKGROUND 
  
 A.    The Crown Entities currently provide certain research and development services to Constar, Inc. 
  
 B.    Crown Cork & Seal Company, Inc. (“Crown”) and Constar International Inc. (“Constar”) are contemplating that an initial public offering will be made of all of
the capital stock of Constar (the “Initial Public Offering”), and Crown and Constar, Inc. both desire for the Crown Entities to continue to provide certain services to Constar, Inc. following the Initial Public Offering.

  
 C.    The Crown Entities and Constar, Inc. desire to enter into this Agreement to set forth
the roles and responsibilities with regard to research and development services to be provided by the Crown Entities to Constar, Inc. following the Initial Public Offering. 
  
 TERMS 
  
 NOW, THEREFORE, for good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Crown Entities and Constar, Inc., for themselves and their successors and assigns, and intending to be legally bound hereby, hereby agree as follows:

  
 1.  Definitions.    Capitalized terms not defined in this
Agreement shall have the meanings ascribed to them in the Corporate Agreement, dated as of the date hereof, between Crown and Constar. As used in this Agreement, the following terms shall have the respective meanings set forth below: 

 
 1.1.  “AAA” shall have the meaning set forth in Section 13.5. 

 
 1.2.  “Additional Services” shall have the meaning set forth in Section 2.4 below.

  
 1.3.  “Benefits Allocation Agreement” shall mean the Benefits
Allocation Agreement, dated as of the date hereof, between Crown and Constar. 

  
 1.4.  “Commitment Percentage” shall
have the meaning set forth in Section 2.1 below. 
  
 1.5.  “Commitment
Period” shall have the meaning set forth in Section 2.1 below. 
  
 1.6.  “Confidential Information” shall have the meaning set forth in Section 8 below. 
  
 1.7.  “Costs” shall have the meaning set forth in Section 3.1 below. 
  
 1.8.  “Developed Intellectual Property” shall have the meaning set forth in Section 6.1 below. 
  
 1.9.  “Force Majeure Event” shall have the meaning set forth in Section 13.2 below. 
  
 1.10.  “Key Carnaud Individuals” shall mean the individuals specified as such on Schedule
A and/or such other individuals that are designated as Key Carnaud Individuals by the parties pursuant to Section 2 from time to time. 
  
 1.11.  “Key Crown Individuals” shall mean the individuals specified as such on Schedule A and/or such other individuals that are designated as Key Crown Individuals by
the parties pursuant to Section 2 from time to time. 
  
 1.12.  “Key
Individuals” shall mean the Key Crown Individuals, the Key Carnaud Individuals and the Key Transferred Individuals and/or such other individuals that are designated as Key Individuals by the parties pursuant to Section 2 from time to time.

  
 1.13.  “Key Transferred Individuals” shall mean the individuals
specified as such on Schedule A and/or such other individuals that are designated as Key Transferred Individuals by the parties pursuant to Section 2 from time to time. 
  
 1.14.  “Key Individual Fees” shall have the meaning set forth in Section 2.1 below. 
  
 1.15.  “Key Individual Services” shall mean the reasonable services, consistent with past
practice of the Crown Entities with respect to similar projects, performed for Constar, Inc. by Key Individuals in accordance with and subject to this Agreement. 
  
 1.16.  “Non-Dedicated Equipment” shall have the meaning set forth in Section 2.3 below. 
  
 1.17.  “Proprietary Rights” shall mean any intellectual property and other proprietary rights,
including, without limitation, any patents, patent applications, industrial design rights, copyrights (and any registration or applications therefor), database rights, trade secrets, all other rights in and to any inventions, discoveries, processes,
formulae, technology, works of authorship and any writings, diagrams, computer programs, compilations and pictorial representations and other works (whether or not copyrightable) relating thereto. 
  
 1.18.  “R&D Fees” shall mean Key Individual Fees and any fees payable for Additional
Services. 
  
 1.19.  “R&D Services” shall mean Additional Services and
Key Individual Services. 
  
 1.20. “Term” shall have the meaning set forth in
Section 5 below. 
  
 2.  Services. 
 2.1.  Key Individuals.    During the Term, and during the Commitment Period for each Key Individual set forth on
Schedule A (the “Commitment Period”), the applicable Crown Entity under whose name such Key Individual is listed on Schedule A shall make such Key Individual available to provide such support and assistance to Constar,
Inc. as is consistent with the skills and experience of such Key Individual, for the applicable percentage of the Key Individual’s working hours per month that is indicated on, and modified in accordance with the terms set forth on, Schedule
A (the “Commitment Percentage”). Constar, Inc. shall have the right to approve the activities of Key Carnaud Individuals and the Key Crown Individuals while providing Key Individual Services in a manner consistent with the
skills and experience of such Key Individuals and shall define and approve the scope of Key Individual Services provided by Key Individuals pursuant to this Agreement. In consideration for such access to each Key Individual, Constar, Inc. agrees to
pay the applicable Crown entity under whose name such Key Individual is listed on Schedule A (i) a fee for each Key Transferred Individual equal to (x) the actual cost to the Crown Entities of compensation and benefits to such Key Individual
per month for each month during which access is provided to such Key Individual plus (y) an annual overhead charge of $16,120, plus phone, delivery and courier costs actually incurred by a Crown Entity, prorated and payable on a monthly basis and
(ii) a fee per each Key Carnaud Individual and Key Crown Individual equal to the product of (x) $12,500 per month for each month during which access is provided to a Key Individual multiplied by (y) such Key Individual’s Commitment Percentage
(collectively, “Key Individual Fees”). The Key Individuals shall, subject to the terms of this Agreement and the Benefits Allocation Agreement, at all times remain employees of the applicable Crown Entity, or one of its Affiliates,
and shall remain subject to the applicable Crown Entity’s policies applicable to its employees. The Crown Entities’ obligation under this Agreement to make a given Key Individual available to Constar, Inc. and the Constar Entities’
obligation to pay Key Individual Fees shall continue for the duration of such Key Individual’s Commitment Period, except that in no event shall such obligations continue beyond the Key Individual’s employment with the applicable Crown
Entity. In the event that a Key Individual ceases to be an employee of the applicable Crown Entity for any reason during the Term other than by taking up employment with Constar, Inc., the applicable Crown Entity shall make commercially reasonable
efforts to find a qualified replacement, whom the applicable Crown Entity may then, with Constar, Inc.’s prior written consent designate as a Key Individual for purposes of this Agreement, to be treated as if such individual were the replaced
Key Individual under the terms of this Agreement; provided, that the applicable Crown Entity shall not be deemed to be in breach of this Agreement (a) if the applicable Crown Entity is unable to hire a qualified replacement for any reason or
(b) as a result 

 
of any delay of whatever duration in the hiring of a qualified replacement. In the event that Constar, Inc. does not consent to a replacement being designated as a Key Individual, neither the
applicable Crown Entity nor any of its Affiliates shall be obligated to provide, or otherwise arrange for the provision of, the Key Individual Services that were previously provided under this Agreement by the Key Individual whose employment with
the applicable Crown Entity has terminated and the applicable Crown Entity shall not be deemed to be in breach of this Agreement. In the event that a Key Individual ceases to be an employee of the applicable Crown Entity for any reason, the
Commitment Period for such Key Individual shall end; provided, that if such Key Individual is replaced pursuant to this Section 2.1, the replacement Key Individual shall assume the balance of the replaced Key Individual’s Commitment
Period. 
  
 2.2.  Activity Reports.    Within 30 days after the
end of each calendar month during the Term, the applicable Crown Entity shall provide Constar, Inc. with monthly reports (based on, and in accordance with, the applicable Crown Entity’s then existing reporting system) on the availability during
such month of Key Individuals to provide Key Individual Services and all Key Individual Services actually provided under this Agreement. In connection with such monthly reports, Key Individuals shall keep a log setting forth the time each such Key
Individual worked in performing the Key Individual Services under this Agreement which shall be supported by weekly time allocation reports with details to be mutually agreed, reviewed by the Constar, Inc. Vice President of Research and Development
or his designee. Any charges above the applicable Commitment Percentage of any Key Individual must be approved by the Constar, Inc. Vice President of Research and Development or his designee in advance. The applicable Crown Entity shall from time to
time provide Constar, Inc. with meeting records, technical records and project review presentations relating to the Key Individual Services provided in connection with Constar, Inc. projects as reasonably appropriate and in accordance with past
practices and in accordance with such reasonable protocols and procedures as the Parties shall mutually agree. So long as the Crown Entities make Key Individuals available to Constar, Inc. in accordance with Section 2.1, Constar, Inc. shall pay the
full Key Individual Fees regardless of the actual time spent on Key Individual Services during any month. Constar, Inc. shall from time to time provide the applicable Crown Entity with meeting records and technical records relating to Constar,
Inc.’s services to Crown as reasonably appropriate and in accordance with past practices and in accordance with such reasonable protocols and procedures as the parties shall mutually agree. 
  

2.3.  Resources. 
  
 (a)  During the Term, Crown shall have no right to use and no right to access the Constar, Inc. owned equipment for any other purpose than the research and development services rendered under
this agreement for Constar, Inc. However, when mutually agreed, Constar, Inc. will use commercially reasonable efforts to provide Crown with R&D services at the same standard billing rate and other terms, including, without limitation, warranty
and indemnification, provided in this Agreement as used by Crown for Additional Services to Constar, Inc. 

 

  
 (b)  During the Term, the Crown Entities shall make
available to the Key Individuals, the non-dedicated equipment set forth on Schedule B (the “Non-Dedicated Equipment”) to the extent necessary for performance of the Key Individual Services on a reasonable basis during normal
business hours or such hours as the parties shall mutually agree, and in accordance with such reasonable protocols and procedures as the parties shall mutually agree from time to time; provided, that the Crown Entities shall not be obligated
to make Non-Dedicated Equipment available for Key Individual Services to the extent that such Non-Dedicated Equipment is reasonably required for other activities of the Crown Entities or their Affiliates. Nothing in this Agreement shall require the
Crown Entities to develop or acquire any facilities or equipment other than as exists as of the Initial Public Offering Date. In lieu of the then existing Non-Dedicated Equipment, the applicable Crown Entity may, in its sole discretion, from time to
time make available to the Key Individuals equivalent alternative equipment, which equipment shall be deemed to be Non-Dedicated Equipment. 
  
 (c)  The Crown Entities shall permit employees of Constar, Inc. to visit the facilities where Key Individual Services are performed. Any such visits shall be reasonable in scope and duration
and shall be conducted during normal business hours. 
  
 (d)  In consideration for the
R&D Fees provided herein, Carnaud agrees to allow Constar, Inc. to store and use the equipment identified on Schedule C in Carnaud’s Wantage facility, consistent with historical practices in Wantage, until the date which is 3 months
from the Initial Public Offering Date or to charge a reasonable fee to be mutually agreed for an extended period of storage. 
  
 (e)  During the Term, Constar, Inc. shall make available to the Crown Entities the thermal imaging camera located in Alsip on a reasonable basis during normal business hours or such hours as
the parties shall mutually agree, and in accordance with such reasonable protocols and procedures as the parties shall mutually agree from time to time; provided, that Constar, Inc. shall not be obligated to make the thermal imaging camera available
to the extent that such equipment is reasonably required for other activities of Constar, Inc. or its Affiliates. 
  
 2.4.  Additional Services.    The Crown Entities will use commercially reasonable efforts to provide Constar, Inc. with (a) research and development services other than the Key Individual Services
and (b) Key Individual Services in excess of a Key Individual’s Commitment Percentage during any month (collectively, “Additional Services”). Such Additional Services shall be provided at the Crown Entities’ standard
billing rate of $12,500 per month per individual providing such services, prorated for the amount of time spent providing Additional Services. In the event that Constar, Inc. receives Key Individual Services from a Key Individual that exceed such
Key Individual’s Commitment Percentage during a month, such excess Key Individual Services shall be considered Additional Services. 
  
 2.5.  Oxygen Transmission Measuring Machines (Illiop). 
  
 (a)  Crown Technologies will complete construction of a new Illiop machine prior to the termination of this agreement, which shall be included as Non-Dedicated Equipment and owned by Crown. Within 90 days after
such new Illiop machine is deemed fully operational by Crown Technologies, Crown shall transfer ownership of the existing Illiop machine in Alsip that is included among the Non-Dedicated Equipment to Constar, Inc. 
  
 (b)  Constar, Inc. and Crown shall make all Illiop machines available to each other on a reasonable basis during
normal business hours or such hours as the parties shall
 

 

 
mutually agree, and in accordance with such reasonable protocols and procedures as the parties shall mutually agree from time to time. 
  
 2.6.  Employees.    Notwithstanding the provisions of the Non-Competition Agreement between Crown and Constar, Constar,
Inc. shall have the option to offer employment to certain Key Carnaud Individuals as indicated on Schedule A. After the Initial Public Offering Date, and on 45 days notice, Constar, Inc. and the Crown Entities can mutually agree to modify the
Commitment Percentage or the Commitment Period, or Constar, Inc. can offer employment to Key Carnaud Individuals. Beginning 90 days after the Initial Public Offering Date, Constar, Inc. may, at its option, decrease the Commitment Percentage of any
Key Carnaud Individuals. Crown agrees to extend the Commitment Period with regard to the Key Carnaud Individuals upon Constar, Inc.’s request at terms to be mutually agreed. Constar, Inc. shall inform the Crown Entities of its intention to
offer employment to such Key Individuals 45 days prior to the proposed transfer date. If the Key Individuals decline the opportunity to transfer employment to Constar, Inc., they will remain employees of the Crown Entities. 
  
 3.  Payment for Costs. 
  
 3.1.  Constar, Inc. shall reimburse the Crown Entities for all third party costs that the Crown Entities incur in connection with the performance
of the R&D Services and for which Crown has obtained written prior approval from Constar, Inc. (the “Costs”), including, by way of example without limitation, equipment repair and maintenance, materials costs, subcontractor
costs, and reasonable travel and accommodation expenses. Without limiting the foregoing Constar, Inc. shall reimburse the applicable Crown Entity for any and all costs associated with repair of equipment that is damaged, becomes inoperable, or
otherwise malfunctions specifically because of the use of such equipment in performing the R&D Services. 
  
 4.  Invoicing and Payment. 
  
 4.1.  The Crown Entities
shall present invoices for R&D Fees and Costs to Constar, Inc. on a monthly basis. All R&D Fees and Costs shall be due within thirty (30) days of receipt of an invoice therefor. 
  
 4.2.  The Crown Entities shall keep reasonably accurate and timely books and records relating to the R&D Fees and Costs in accordance with the
Crown Entities’ standard record-keeping procedures and which shall be supported by purchase approval documents and weekly timekeeping reports available to the Constar, Inc. Vice President of Research and Development or his designate, and shall
maintain such books and records until one year after the termination or expiration of this Agreement. Constar, Inc. shall have the right, during the Term, at Constar, Inc.’s own expense, to audit the Crown Entities’ books and records for
the purpose of verifying the R&D Fees and Costs. Such audits shall be made not more than once per year, on not less than 15 days’ written notice, during regular business hours and by independent auditors selected by Constar, Inc. and
acceptable to the Crown Entities, such acceptance not to be unreasonably withheld, conditioned or delayed. In the event such audit reveals any inaccuracies in the R&D Fees and Costs reported by the Crown Entities, the parties shall take action
promptly to correct
 

 

 
such inaccuracies, including, without limitation, the payment or refund, as the case may be, of R&D Fees and Costs to the extent that the amount actually paid by Constar, Inc. is more or less
than the amount accurately due. 
  
 4.3. All sums referenced in this Agreement are expressed
exclusive of VAT or other sales tax, which shall be paid by Constar, Inc. at the time and manner prescribed by law. 
  
 5.  Term. 
  
 5.1.  The term of this Agreement
shall begin on the Initial Public Offering Date and, unless terminated as provided for herein, shall continue until December 31, 2003 (the “Term”). The Term of this Agreement can be extended beyond this date, if mutually agreed by
Constar, Inc. and the Crown Entities. 
  
 5.2.  The following shall be considered events of
default and shall give rise to a right of either Crown Entity to terminate this Agreement: (i) Constar, Inc. fails to make timely payments for invoiced R&D Fees and Costs, subject to a 30-day cure period after notice regarding such breach, (ii)
Constar, Inc. materially breaches any other applicable provision of this Agreement, subject to a 30-day cure period after notice regarding such breach, or (iii) Constar or Constar, Inc. experiences a change of Control such that Constar or Constar,
Inc. is controlled by a competitor of Crown or Constar, Inc. (provided that such termination shall not be effective until six months from the date of the change of Control). If Constar or Constar, Inc. suffers a Bankruptcy Event, Crown shall have
the right to unilaterally modify the payment terms set forth in Section 4.1 of the Agreement at any time after such Bankruptcy Event. Crown shall promptly notify Constar, Inc. of any such modifications to the payment terms of this Agreement.

  
 5.3.  The following shall be considered events of default and shall give rise to a
right of Constar, Inc. to terminate this Agreement: (i) either Crown Entity materially breaches any other applicable provision of this Agreement, subject to a 30-day cure period after notice regarding such breach or (ii) either Crown Entity or Crown
experiences a change of Control such that either Crown Entity or Crown is controlled by a competitor of Constar, Inc. or Crown (provided that such termination shall not be effective until six months from the date of the change of Control).

  
 6.  Intellectual Property. 
  

6.1.  As between the Crown Entities and Constar, Inc., Constar, Inc. shall own all right, title and interest in and to any Proprietary Rights
that are developed, generated or created in the performance of the R&D Services (the “Developed Intellectual Property”). Notwithstanding anything to the contrary in this Agreement, Developed Intellectual Property shall not
include any Proprietary Rights that either of the Crown Entities hold or own prior to, or as a result of activities other than, performance of the R&D Services, and as between the Crown Entities and Constar, Inc., the Crown Entities own and at
all times shall own all right, title and interest in and to such Proprietary Rights and to any improvements or modifications of such Proprietary Rights. The Crown Entities hereby irrevocably and unconditionally assign and transfer to Constar, Inc.
 

 

 
all rights of every kind, nature or description, whether now known or hereafter devised, that the Crown Entities may have in or to such Developed Intellectual Property. The Crown Entities shall,
at Constar, Inc.’s request, obtain, execute and deliver such other instruments and documents, in form and substance reasonably satisfactory to Constar, Inc., as may be necessary to further evidence, perfect, maintain and effectuate the rights
granted to Constar, Inc. hereunder, including without limitation causing the Key Individuals and/or any other inventors to execute and deliver such assignments and inventions disclosures as may be necessary to transfer the Developed Intellectual
Property to Constar, Inc. In addition, at Constar, Inc.’s request and expense, Crown shall provide reasonable cooperation to Constar, Inc. in the event that Constar, Inc. elects at its discretion to file and prosecute any patent applications as
part of the Developed Intellectual Property. 
  
 6.2.  For Developed Intellectual Property,
Constar, Inc. will bear all patent filing fees, renewal fees, and external legal fees. For Developed Intellectual Property, the Crown Entities will charge as Additional Services any labor costs incurred by Crown Entities personnel in the preparation
and filing for registered patent and trademark protection. 
  
 7.  Warranty; Limitation
of Liability. 
  
 7.1.  The Crown Entities warrant that the R&D Services shall be
performed in a workmanlike manner. In the case of any work which is not in compliance with this warranty that is brought to its attention within a commercially reasonable time, but no more than 90 days, after the work is performed, the Crown
Entities agree (i) to refund to Constar, Inc. any charges for services or materials pertaining to such work or (ii) to re-perform the work. OTHER THAN THE ABOVE WARRANTY, THE CROWN ENTITIES MAKE NO WARRANTY, WHETHER OF MERCHANTABILITY, FITNESS OR
OTHERWISE, EXPRESS OR IMPLIED, IN FACT OR BY LAW, AND THE CROWN ENTITIES SHALL HAVE NO FURTHER OBLIGATION OR LIABILITY UNDER THE ABOVE WARRANTY OR WITH RESPECT TO THE R&D SERVICES. THE CROWN ENTITIES SHALL IN NO EVENT BE LIABLE FOR PUNITIVE,
CONSEQUENTIAL OR INCIDENTAL DAMAGES. 
  
 7.2.  Subject to the above provisions, Constar,
Inc. shall not bring any other action arising hereunder unless such action is brought within one year after the date such cause of action accrues. 
  
 7.3.  The Crown Entities shall not be liable for, and Constar, Inc. assumes responsibility for, all personal injury and property damage resulting
from the provision of R&D Services hereunder, except to the extent any such personal injury or property damage results from the willful misconduct of the Crown Entities. 
  
 8.  Confidentiality; Disclosures. 
  
 8.1.  Confidentiality. Each party agree (a) to maintain all information, whether in written, oral, electronic or other form, necessary for or utilized or received by such party
 

 

 
pursuant to any terms of this Agreement, as the case may be, including, without limitation, prices, payment terms, technical knowledge, know-how, material, manufacturing, Proprietary Rights,
tooling and equipment specifications and other information necessary to carry out the terms of this Agreement and any proprietary or confidential inventions, discoveries, processes, formulae or technology developed, generated or created in the
performance of the R&D Services, as the case may be (the “Confidential Information”), as secret and confidential and (b) not to disclose the Confidential Information to any third person or party (except for employees, counsel,
contractors, customers, consultants or vendors who have a need to know and are informed of the confidential nature of such information by the disclosing party). Each party shall accept responsibility and be liable for any disclosure by any third
person of any Confidential Information disclosed to such third person by such party. The parties will use the same measures to maintain the confidentiality of the Confidential Information of any other party in its possession or control that it uses
to maintain the confidentiality of its own Confidential Information of similar type and importance. Notwithstanding the foregoing, any party or their Affiliates may describe this Agreement in, and include this Agreement with, filings with the
U.S. Securities and Exchange Commission and any related prospectuses, including such filings or prospectuses in connection with any offering of securities. Confidential Information will not include information that (i) is in or enters the public
domain without breach of this Agreement, or (ii) the receiving party lawfully receives from a third party without restriction on disclosure and, to the receiving party’s knowledge, without breach of a nondisclosure obligation. 

 
 8.2.  Disclosure to Governmental Agency. Notwithstanding the foregoing, each party shall be
permitted to disclose the Confidential Information and/or any portion thereof (i) to a governmental agency or authority as required in response to a subpoena therefor, (ii) in connection with formal requests for discovery under applicable rules of
civil procedure in a legal action before a court of competent jurisdiction to which such party is a party and (iii) as otherwise required by law; provided, however, that, in any such case, each party shall notify the other party as
early as reasonably practicable prior to disclosure to allow such party to take appropriate measures to preserve the confidentiality of such information at the expense of such party. 
  
 8.3.  Ownership of Information. All Confidential Information supplied or developed by either party will be and remain the sole and
exclusive property of the party who supplied or developed it. Nothing in this Section 8.3 shall derogate Constar, Inc.’s ownership rights in Developed Intellectual Property as provided in Section 6. 
  
 8.4.  Return of Confidential Information. Upon the written request of a party which has disclosed
information covered by this Section 8 in written, printed or other tangible form, all such readily available information, all copies thereof, including samples or materials, and all notes or other materials derived from such information shall be
returned to the party which disclosed such information. 
  
 9.  Independent
Contractors.    None of the parties is now, nor shall it be made by this Agreement, an agent or legal representative of any other party for any purpose, and no party has
 

 

 
any right or authority to create any obligation, express or implied, on behalf of any other party, to accept any service of process upon it, or to receive any notices of any kind on its behalf.
All activities by the Crown Entities hereunder shall be carried on by the Crown Entities as independent contractors and not as agents for Constar, Inc. 
  
 10.  Security.    Crown will provide commercially reasonable physical protection and shall put in place commercially
reasonable procedures to restrict access by unauthorized persons to the Constar, Inc. work area, documents, work product, laboratory and equipment environment, and to all forms of access to computerized information by unauthorized persons. Crown
shall not be responsible or liable for any breach of security that arises out of conduct by Constar, Inc.’s employees, counsel, contractors, consultants or vendors. Access to Constar, Inc. restricted areas and sources of information must be
made only upon authorization by Constar, Inc.’s Vice President of Research and Development (or a designee) for any third person or party who is not an employee, counsel, contractor, consultant or vendor of Constar, Inc. with a project-related
need to such access and who has not executed a confidentiality agreement which conforms to the requirements of Section 8 above concerning confidentiality. Access to Crown Entity restricted areas and sources of information must be made only upon
authorization by Crown’s Executive Vice President of Research and Development (or a designee) for any third person or party who is not an employee, counsel, contractor, consultant or vendor of Crown with a project-related need to such access
and who has not executed a confidentiality agreement which conforms to the requirements of section 8 above concerning confidentiality. Constar, Inc. will bear the one-time costs of modifications, and, if needed, removal, to conform to this
requirement at Wantage and Alsip subject to Constar, Inc.’s prior approval. 
  
 11.  Other Development Activities.    Constar, Inc. acknowledges that the Crown Entities currently undertake, and may undertake in the future, various research and development activities for other
businesses. Subject to Sections 6 and 9, nothing in this Agreement shall be construed to prohibit the Crown Entities from continuing to undertake any such activities; provided, that nothing in this Section 11 shall relieve Crown of its obligations
under the Non-Competition Agreement, dated as of the date hereof, between Crown and Constar. 
  
 12.  Indemnification.    With respect to R&D Services, Constar, Inc. shall defend, indemnify and hold the Crown Entities and their Affiliates and their respective officers, directors,
employees, successors and permitted assigns harmless against any and all liability, damage, loss, cost or expense arising out of (i) the provision of R&D Services or any products liability arising therefrom (except any liability directly related
to and directly caused by the gross negligence or willful misconduct of the Crown Entities in providing such R&D Services) and (ii) all claims, suits or actions for bodily injuries suffered in connection with the provision of the R&D
Services and arising out of Constar, Inc.’s breach of this Agreement, negligence or misconduct. Furthermore, Constar, Inc. shall indemnify, defend and hold the Crown Entities and their Affiliates and their respective officers, directors,
employees, successors and permitted assigns harmless against all damages, claims, judgments, decrees, costs, expenses and demands for
 

 
unfair competition or infringement of any United States or foreign trademark or copyright as a direct result of the provision of R&D Services conforming to the specifications required by
Constar, Inc. or the failure of the provision of such R&D Services to comply with any federal, state, local or other law or regulation. The Crown Entities shall not settle any claim for which it is entitled to indemnification hereunder without
the written consent of Purchaser, which shall not be unreasonably withheld. 
  
 13.  Miscellaneous. 
  
 13.1.  Successors/No Third
Party Beneficiaries.    This Agreement shall not be assignable, except that (i) a Crown Entity may, after giving notice to Constar, Inc., assign its rights and obligations under this Agreement; provided, that a Crown
Entity shall not assign its rights and obligations under this Agreement to a competitor of Constar, Inc. in the PET preform and container industry without the prior written consent of Constar, Inc., and (ii) Constar, Inc. may, and hereby gives
notice to Crown that it intends to, pledge its rights and obligations under this Agreement to Constar’s lenders as collateral to secure indebtedness outstanding under Constar’s senior secured credit facility and all renewals, refundings,
refinancings and replacements thereof. This Agreement shall be binding upon, and shall inure to the benefit of, the parties hereto and their respective successors and permitted assigns. Nothing in this Agreement, express or implied, is intended to
or shall (a) confer on any person other than the parties hereto and their respective successors or permitted assigns any rights (including third party beneficiary rights), remedies, obligations or liabilities under or by reason of this Agreement, or
(b) constitute the parties hereto as partners or as participants in a joint venture. This Agreement shall not provide third parties with any remedy, claim, liability, reimbursement, cause of action or other right in excess of those existing without
reference to the terms of this Agreement. 
  
 13.2.  Force
Majeure.    Neither Supplier nor Purchaser shall be responsible for any failure or delay in performance due to causes beyond their respective control, including, without limitation, earthquake, fire, storm, flood, freeze,
labor disputes, transportation embargoes, acts of God or of any government and acts of war or terrorism (any of the foregoing, a “Force Majeure Event”). Any party, if affected by any such cause, may, upon written notice to the other
parties specifying the reasons therefor, reduce its obligations to the other to the extent it is necessarily prevented, hindered or delayed as a result of the Force Majeure Event. Notwithstanding anything to the contrary in this Agreement, this
provision shall not apply to or otherwise excuse the failure to pay any uncontested R&D Fees or Costs due under this Agreement when due. 
  
 13.3.  Notices.    All notices and other communications required or permitted hereunder shall be in writing, shall be deemed duly given upon actual receipt, and
shall be delivered (a) in person, (b) by registered or certified mail, postage prepaid, return receipt requested or (c) by facsimile or other generally accepted means of electronic transmission (provided that a copy of any notice delivered pursuant
to this clause (c) shall also be sent pursuant to clause (b)), addressed as follows: 
  
 if to
Carnaud, to: 

  
 CarnaudMetalbox plc 
 Downsview Road 
 Wantage 
 Oxfordshire OX12 9 BP 
 Attention:

 Facsimile: 44.1235.402578 
  
 if to Crown Technologies, to: 
  
 Crown Cork &
Seal Technologies Corporation 
 11535 S. Central Avenue 
 Alsip, IL 60482-2523 
 Attention: 
 Facsimile: 
  
 if to either Crown Entity, with a copy to: 
  
 Crown Cork & Seal Company, Inc.

 One Crown Way 
 Philadelphia, PA 19154 
 Attention: 
 Facsimile: 
  
 if to Constar, Inc., to: 

 
 Constar, Inc. 
 One Crown Way 
 Philadelphia, PA 19154-4599 
 Attention: Chief Financial Officer 
 Facsimile: 
  
 or to such other addresses or telecopy numbers as may be specified by like notice to the other parties. 

 
 13.4.  Governing Law.    This Agreement shall be governed by and construed
in accordance with the laws of the Commonwealth of Pennsylvania. 
  
 13.5.  Dispute
Resolution: Negotiation and Arbitration. 
  
 (a)  The parties shall attempt to resolve
any dispute arising out of or relating to this Agreement promptly by negotiation in good faith between executives who have authority to settle the dispute. A party shall give the other parties written notice of any dispute not resolved in the
ordinary course of business. Within ten Business Days after delivery of such notice, the party receiving notice shall submit to the others a written response thereto. The notice and the
 

 
response shall include: (i) a statement of each party’s position(s) regarding the matter(s) in dispute and a summary of arguments in support thereof, and (ii) the name and title of the
executive who will represent that party and any other Person who will accompany that executive. 
  
 (b)  Within 10 Business Days after delivery of the notice, the designated executives shall meet at a mutually acceptable time and place, and thereafter, as often as they reasonably deem necessary, to attempt to resolve the
dispute. All reasonable requests for information made by one party to any other shall be honored in a timely fashion. All negotiations conducted pursuant to this Section 13.5 (and any of the parties’ submissions in contemplation hereof) shall
be deemed Confidential Information and shall be treated by the parties and their representatives as compromise and settlement negotiations under the United States Federal Rules of Evidence and any similar state rules. 
  
 (c)  If the matter in dispute has not been resolved within 30 days after the first meeting of the executives to
attempt to resolve the dispute, either party may submit the dispute to binding arbitration to the Philadelphia, Pennsylvania office of the American Arbitration Association (“AAA”) in accordance with the procedures set forth in the
Commercial Arbitration Rules of the AAA. 
  
 (d)  The Commercial Arbitration Rules of the
AAA, as modified or revised by the provisions of this Section 13.5, shall govern any arbitration proceeding hereunder. The arbitration shall be conducted by three arbitrators selected pursuant to Rule 13 of the Commercial Arbitration Rules, and
pre-hearing discovery shall be permitted if and only to the extent determined by the arbitrator to be necessary in order to effectuate resolution of the matter in dispute. The arbitrator’s decision shall be rendered within 30 days of the
conclusion of any hearing hereunder and the arbitrator’s judgment and award may be entered and enforced in any court of competent jurisdiction. 
  
 (e)  Resolution of disputes under the procedures of this Section 13.5 shall be the sole and exclusive means of resolving disputes arising out of
or relating to this Agreement; provided, however, that nothing herein shall preclude the Parties from seeking in any court of competent jurisdiction temporary or interim injunctive relief to the extent necessary to preserve the subject matter
of the dispute pending resolution under this Section 13.5. 
  
 13.6.  Consent to
Jurisdiction.    The Crown Entities and Constar, Inc. hereby agree and consent to be subject to the exclusive jurisdiction of the United States District Court for the Eastern District of Pennsylvania, and in the absence of
such Federal jurisdiction, the parties consent to be subject to the exclusive jurisdiction of any state court located in the City of Philadelphia and hereby waive the right to assert the lack of personal or subject matter jurisdiction or improper
venue in connection with any such suit, action or other proceeding. In furtherance of the foregoing, each of the parties (i) waives the defense of inconvenient forum, (ii) agrees not to commence any suit, action or other proceeding arising out of
this Agreement or any transactions contemplated hereby other than in any such court (other than the mandatory submission to arbitration in accordance with Section 13.5), and (iii) agrees that a final judgment
 

 
in any such suit, action or other proceeding shall be conclusive and may be enforced in other jurisdictions by suit or judgment or in any other manner provided by law. 
  
 13.7.  Entire Agreement.    This Agreement constitutes the entire understanding of
the parties hereto with respect to the subject matter hereof and supersedes any prior agreement or understanding, written or oral, relating to the subject matter of this Agreement. 
  
 13.8.  Section Headings; Interpretive Issues.    The section and paragraph headings contained in this Agreement are for
reference purposes only and shall not in any way affect the meaning or interpretation of this Agreement. The Crown Entities and Constar, Inc. have participated jointly in the drafting and negotiation of this Agreement. In the event any ambiguity or
question of interpretation or intent arises, this Agreement shall be construed as if drafted jointly by the parties and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of
this Agreement. 
  
 13.9.  Counterparts.    This Agreement and
any amendments hereto may be executed in any number of counterparts, each of which shall be deemed an original instrument, but all of which together shall constitute but one and the same agreement. Delivery of an executed counterpart of a signature
page to this Agreement by facsimile shall be as effective as delivery of a manually executed counterpart of this Agreement. 
  
 13.10.  Severability.    If any term or provision of this Agreement or the application thereof to any person or circumstance shall, to any extent, be held invalid
or unenforceable by a court of competent jurisdiction, the remainder of this Agreement or the application of any such term or provision to persons or circumstances other than those as to which it is held invalid or unenforceable shall not be
affected thereby, and each term and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. If any of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to
duration, scope, activity or subject, it shall be construed by limiting and reducing it, so as to be valid and enforceable to the extent compatible with the applicable law or the determination by a court of competent jurisdiction. 

 
 13.11.  Effectiveness.    The terms of this Agreement shall not become
effective until the Initial Public Offering Date. 
  
 13.12.  Pronouns.    Whenever the context may require, any pronouns used herein shall be deemed also to include the corresponding neuter, masculine or feminine forms. 
  
 13.13.  Further Assurances.    The parties shall execute, acknowledge and deliver, or
cause to be executed, acknowledged and delivered, such instruments and take such other action as may be necessary or advisable to carry out their obligations under this Agreement and under any exhibit, document or other instrument delivered pursuant
hereto. 
  
 13.14.  Amendment and Modification.    This
Agreement may not be amended or modified except by written instrument duly executed by the parties hereto. No course of dealing between
 

 
or among any persons having any interest in this Agreement will be deemed effective to modify, amend or discharge any part of this Agreement or any rights or obligations of any person under or by
reason of this Agreement. 
  
 [Signatures appear on next page] 
  

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed on the day and year first above written.

  
 
	 CARNAUDMETALBOX PLC
 
	 
	 By:
 	 	 /s/    JOHN
DAVIDSON        
 

	  	 	 John Davidson
 Director
 

 
  
 
	 CROWN CORK & SEAL TECHNOLOGIES CORPORATION
 
	 
	 By:
 	 	 /s/    Daniel A. Abramowicz        
 

	  	 	 Daniel A. Abramowicz
 EVP-Corporate Technologies
 

 
  
 
	 CONSTAR, INC.
 
	 
	 By:
 	 	 /s/    JAMES C.
COOK        
 

	  	 	 James C. Cook
 Vice President
and Chief Financial Officer
 

 

 SCHEDULE A—KEY INDIVIDUALS 
  
 Key Crown Individuals 
  
 
	 Name
 
	    	 Commitment Percentage
 
	    	 Commitment Period
 
	  	 Option to Hire
 

	 [***]
 	    	 50%
 	    	 From the Initial Public Offering Date until 6 months after the Initial Public Offering Date
 	  	 No
 
	 
	 [***]
 	    	 30%
 	    	 From 6 months after the Initial Public Offering Date until December 31, 2003
 	  	 No
 
	 
	 [***]
 	    	 25%
 	    	 From the Initial Public Offering Date until 6 months from the Initial Public Offering Date
 	  	 No
 
	 
	 [***]
 	    	 20%
 	    	 From 6 months after the Initial Public Offering Date until December 31, 2003
 	  	  
	 
	 [***]
 	    	 50%
 	    	 From the Initial Public Offering Date until 6 months from the Initial Public Offering Date
 	  	 Yes
 

 
  
 Key Carnaud Individuals 
  
 
	 Name
 
	    	 Commitment Percentage
 
	    	 Commitment Period
 
	  	 Option to Hire
 

	 [***]
 	    	 100%
 	    	 From the Initial Public Offering Date up to 6 months from the Initial Public Offering Date
 	  	 Yes
 
	 
	 [***]
 	    	 40%
 	    	 From the Initial Public Offering Date up to 6 months from the Initial Public Offering Date
 	  	 No
 
	 
	 [***]
 	    	 90%
 	    	 From the Initial Public Offering Date up to 6 months from the Initial Public Offering Date
 	  	 Yes
 

 
 

	[***]
	 
	Confidential treatment requested 
 

 
	 
	 [***]
 	    	 90%
 	    	 From the Initial Public Offering Date up to 6 months from the Initial Public Offering Date
 	    	 Yes
 
	 
	 [***]
 	    	 90%
 	    	 From the Initial Public Offering Date up to 6 months from the Initial Public Offering Date
 	    	 Yes
 
	 
	 [***]
 	    	 40%
 	    	 From the Initial Public Offering Date up to 6 months from the Initial Public Offering Date
 	    	 Yes
 

 
  
 Key Transferred Individuals (*)—Crown Technologies 
  
 
	 Name
 
	    	 Commitment Percentage
 
	  	 Commitment Period
 

	 [***]
 	    	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 
	 
	 [***]
 	    	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 
	 
	 [***]
 	    	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 
	 
	 [***]
 	    	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 
	 
	 [***]
 	    	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 
	 
	 [***]
 	    	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 

 
 

	[***]
	 
	Confidential treatment requested 
 

 
	 
	 [***]
 	  	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 
	 
	 [***]
 	  	 100%
 	  	 From the Initial Public Offering Date until Transfer of Employment
 

 
  

	(*)
	 
	Employment shall be terminated by the applicable Crown Entity and employment will be offered by Constar, Inc. pursuant to the terms of the Benefits Allocation
Agreement. In accordance with the Benefits Allocation Agreement, such termination and offer of employment shall occur (i) with respect to Key Transferred Individuals who, as of the Initial Public Offering Date, are in the process of seeking
permanent residency in the United States, the later of (x) 6 months from the Initial Public Offering Date and (y) the date that such permanent residency is granted and (ii) with respect to Key Transferred Individuals who, as of the Initial Public
Offering Date, are not in the process of seeking permanent residency in the United States, 6 months from the Initial Public Offering Date. 
 

  
 A Key Individual’s available hours for each month shall equal: 
  
 (1)  the Key Individual’s Commitment Percentage (as set forth above) 
  
 multiplied by

  
 (2) 
  
 (a)  with respect to Key Carnaud Individuals, 7.5 hours per day times the number of calendar days in the month, which number of hours (i) shall be reduced by 7.5 hours per day times the
number of Saturdays and Sundays during the month, and (ii) shall be further reduced by all hours during the month that the Key Carnaud Individual charges to holidays, vacation days, sick days and other personal time to which such Key Carnaud
Individual is entitled under the terms of his employment with Carnaud; and 
  
 (b)  with respect to Key
Crown Individuals and Key Transferred Individuals, 8 hours per day times the number of calendar days in the month, which number of hours (i) shall be reduced by 8 hours per day times the number of Saturdays and Sundays during the month, and (ii)
shall be further reduced by all hours during the month that the Key Individual charges to holidays, vacation days, sick days and other personal time to which such Key Individual is entitled under the terms of his employment with Crown Technologies.

  
 In the event that a Key Individual’s Commitment Period begins or ends in the middle of a month available
hours for such month shall be prorated accordingly. 
 

	[***]
	 
	Confidential treatment requested 
 

 SCHEDULE B—NON-DEDICATED EQUIPMENT 
  
 Crown Technologies (Alsip): 
  

	·
	 
	Nissei injection molder 
 

  

	·
	 
	Oberburg compression molder 
 

  

	·
	 
	AHP slitter 
 

  

	·
	 
	Netstal injection molder and ancillaries 
 

  

	·
	 
	Ancillary equipment like A frames etc. 
 

  

	·
	 
	The remaining quality lab equipment including: torque meter, capping machine and the cap dimensional measurement device. 
 

 

	·
	 
	Existing Illiop Machine (will be transferred after new Illiop machine is deemed fully operational pursuant to the terms of this Agreement) 

  

	·
	 
	New Illiop Machine (when constructed pursuant to the terms of this Agreement) 
 

  

	·
	 
	Gas chromatography units (except 5890 unit) 
 

  

	·
	 
	Thermal imaging camera 
 

  

	·
	 
	Differential scanning calorimeter 
 

  
 Carnaud (Wantage): 
  

	·
	 
	Extrusion blow molder 
 

  

	·
	 
	Oxysense analysis system 
 

  

	·
	 
	Filling equipment 
 

 SCHEDULE C—CONSTAR, INC. WANTAGE EQUIPMENT 
  

	·
	 
	Starshield coating line 
 

  

	·
	 
	Blow molder LBO1E 
 

  

	·
	 
	Blow molder LBO1 
 

  

	·
	 
	Gawis bottle measuring equipment 
 

  

	·
	 
	Bottle trimmer 
 

  

	·
	 
	Bottle section weight cutter 
 

  

	·
	 
	Illiop machine 
 

  

	·
	 
	Magnamike measuring deviceLICENSE AND ROYALTY SHARING AGREEMENT

  
 Exhibit 10.9 
 Execution Copy 
  
 LICENSE AND ROYALTY-SHARING AGREEMENT 
  
 This License and Royalty-Sharing Agreement (the “Agreement”), dated as of November 20, 2002, is between Constar
International Inc., a Delaware corporation (“Constar”) and Crown Cork & Seal Technologies Corporation, a Delaware corporation (“Crown”). 
  
 Background 
  
 A. Pursuant to a Master
Assignment and Assumption Agreement dated as of the date hereof, Crown is assigning to Constar certain patents and patent applications relating to oxygen-scavenging technology. Constar has the right to sublicense other patents and patent
applications relating to oxygen-scavenging technology under a license agreement with Rexam AB (“Rexam”). 
  
 B. Subject to the terms of this Agreement, Constar wishes to grant to Crown, and Crown wishes to accept, a license and sublicense under the Oxbar Technology (as defined below) for use in products other than products manufactured with
polyethylene terephthalate (“PET”), and a license to use the Marks (as defined below) on or in connection with such products. 
  
 C. Subject to the terms of this Agreement, Constar wishes to pay to Crown, and Crown wishes to accept, a percentage of royalties that Constar or its Affiliates receive from licenses of the Oxbar Technology to other parties.

  
 Terms 
  
 NOW, THEREFORE, the parties hereto, intending to be legally bound, and for good and valuable consideration, the adequacy of which is hereby acknowledged, agree as follows: 
  
 1. DEFINITIONS 
  
 Capitalized terms not defined in this Agreement shall have the meanings ascribed to them in the Corporate Agreement, dated as of the date hereof, between Crown Cork and Seal Company, Inc. and Constar
International Inc. As used in this Agreement, the following terms shall have the respective meanings set forth below: 
  
 1.1. “Affiliate” shall mean any entity which controls, is controlled by, or is in common control with, a party to this Agreement. For purposes of this definition, “control” shall mean ownership, directly or
indirectly, of at least fifty percent (50%) of the voting stock or shareholders’ equity of a corporation or, in the case of a non-corporate entity, a right to receive at least fifty percent (50%) of either the profits or the assets upon
dissolution of such entity, or, in either case, the right to elect a majority of the board of directors (or similar governing body) of an entity.  

  
 1.2. “Constar Oxbar Patents” means those Oxbar Patents that are
now owned or hereafter acquired by Constar or its successors or assigns. 
  
 1.3. “Contract Year”
means (i) the period of time commencing on the Initial Public Offering Date and ending on the last day of the twelfth (12th) calendar month thereafter and (ii) each subsequent period of twelve (12) consecutive calendar months. 
  
 1.4. “Licensed Field” means the manufacture, use, offering for sale, sale, and importation of Licensed Products. 
  
 1.5. “Licensed Products” means products, other than products manufactured with PET, that would infringe one or more valid and enforceable claims of the Oxbar Patents if not for this
Agreement. For purposes of this definition, the claims of the Oxbar Patents are deemed to be valid and enforceable unless and until held invalid or unenforceable in a final judgment by any court of competent jurisdiction and from which no appeal
either has been or can be taken. 
  
 1.6. “Marks” means the trademark OXBAR and any other marks
listed on Exhibit B. 
  
 1.7. “Oxbar Patents” means the patents and patent applications
listed on Exhibit A, together with any other patents or patents applications relating to oxygen-scavenging technology that are licensed by Constar or to Constar under the Rexam Agreement, any patents or patent applications on improvements to
the inventions described in such patents or patent applications that Constar owns or has the right to sublicense to Crown hereunder, and any reissue, reexamination, extension, division, continuation or continuation-in-part of any of the foregoing.

  
 1.8. “Oxbar Technology” means (i) the Oxbar Patents, and (ii) all unpatented technology,
know-how, trade secrets, processes, formulae, technical information, data, drawings, plans, specifications, formulation and reports, and all other general and specific proprietary knowledge, experience, techniques, and information relating to
oxygen-scavenging technology that Constar owns, or has the right to sublicense to Crown hereunder, as of the Initial Public Offering Date or thereafter (the “Oxbar Trade Secrets”). 
  
 1.9. “Rexam Agreement” means the patent cross-licensing agreement dated May 17, 1988 to which Rexam and Constar are currently parties, as such agreement
may be amended or restated, or any subsequent agreement between Rexam or its Affiliates, and Constar or its Affiliates, relating to the Oxbar Patents. 
  
 1.10. “Rexam Oxbar Patents” means those Oxbar Patents now owned or hereafter acquired by Rexam or its successors or assigns. 
  
 1.11. “Third Party” means a party other than Constar, Crown, and their Affiliates. 
  
 1.12. “Third-Party Royalties” means gross proceeds received by Constar or its Affiliates in consideration of licenses and sublicenses of the Oxbar
Technology to Third Parties, but shall not include amounts that are (i) charged reasonably and in good faith by Constar or its Affiliates to a Third Party for technical services, (ii) calculated as compensation for employees’ or
contractors’ time, physical resources, and/or third-party expenses reasonably required to provide such technical services, and (iii) invoiced to Third Parties as charges separate from the 

 
 2 

 
royalty or other fee for licenses and sublicenses. Notwithstanding the foregoing, in the event that any Rexam Agreement provides that Constar or its Affiliates will share with Rexam or its
Affiliates proceeds received by Constar or its Affiliates in consideration of licenses and sublicenses of the Oxbar Technology to Third Parties, then Crown and Constar shall negotiate in good faith to amend this Agreement to define “Third-Party
Royalty” in a manner substantially similar to the definition of the corresponding term in such Rexam Agreement, provided that Crown shall not be obligated to negotiate for, or agree to, any such amendment to this Agreement that is likely to
reduce materially the amount of Royalty Sharing Payments owed to Crown hereunder. For the avoidance of doubt, the parties acknowledge that neither (i) Crown’s consent to any change to the Rexam Agreement, nor (ii) Crown’s consent to any
percentage of Third-Party Royalties that Constar may agree to pay under the Rexam Agreement, shall be required as a condition to Constar’s agreement to any such change or percentage. 
  
 2. LICENSE GRANT 
  
 2.1. Subject to the terms and conditions set forth in this Agreement, Constar grants to Crown a non-exclusive, worldwide, royalty-free license and sublicense under the Oxbar Technology to make, have made, use, offer for sale, sell
and import Licensed Products, including the right to make and have made oxygen-scavenging material for use in Licensed Products that are sold by Crown or its Affiliates, and including the right to sublicense and further sublicense the Oxbar
Technology as specifically provided in Section 9 below. Notwithstanding the foregoing, the rights granted to Crown hereunder shall specifically exclude any rights granted to Chevron Chemical Company LLC, now known as Chevron Phillips Chemical
Company LP, and Chevron Research and Technology Company (collectively “Chevron”), in the licensing agreement among Chevron, PLM AB, now known as Rexam AB, and CarnaudMetalbox Technology plc dated December 17, 1993, as amended December 20,
1999, which license has been assigned by CarnaudMetalbox Technology plc to Crown, and by Crown through its Affiliates to Constar (the “Chevron Agreement”). 
  
 3. OBLIGATIONS OF CROWN 
  
 3.1. Marking. Crown shall comply with all applicable laws relating to the marking of Licensed Products with suitable patent notices. 
  
 3.2. Registration of License. To the extent that the patent laws of any country require the recordation or registration of this Agreement to ensure the continued validity and enforceability of
the Oxbar Patents or this Agreement, Crown shall, at its own expense, take whatever action is necessary to record or obtain registration of this Agreement, including the filing of all necessary documents and payment of all required fees.

  
 3.3. Compliance With Laws and Regulations. Crown shall comply with all laws, regulations, rulings and
requirements of any and all governmental authorities having jurisdiction over the subject matter of this Agreement. 
  
 3.4. Developments. Crown shall, during the term of this Agreement, periodically inform Constar as to developments and improvements to the Oxbar Technology created by or on behalf of Crown or acquired by Crown (collectively,
“Developments”). Crown shall disclose all Developments to Constar before they are publicly disclosed. Crown shall grant, and hereby does grant, a worldwide, perpetual, non-exclusive, royalty-free license under the Developments,
including an unlimited right to sublicense, to exploit the Developments, including without limitation the right to make, have made, use, sell, offer for sale, and import any product embodying such Developments. 

 
 3 

  
 4. MAINTENANCE; REXAM AGREEMENT 
  
 4.1. Constar shall at its own cost take reasonable actions: 
  
 (a) to prosecute patent applications comprised in the Constar Oxbar Patents as have not been granted as of the date hereof, and 
  
 (b) to maintain in force all of its patents as may from time to time be comprised in the Constar Oxbar Patents.

  
 4.2. Where Constar no longer wishes to prosecute an application or maintain a Constar Oxbar Patent in force that
could be so reasonably prosecuted or maintained in force, it shall offer assignment of the said application or patent to Crown. 
  
 4.3. Save as aforesaid, Constar undertakes not to assign, license or otherwise deal in the Oxbar Patents in such manner as to deprive Crown of the rights granted under this Agreement. 
  
 4.4. Constar shall not agree to any amendment or restatement of the Rexam Agreement that would impair its authority to grant Crown the
licenses and sublicenses under the Oxbar Patents described in this Agreement. Constar shall take steps to enforce Rexam’s obligations under the Rexam Agreement as reasonably necessary to allow Crown to exercise the rights granted hereunder. To
the extent that, under applicable law, Crown has the authority to agree to an amendment of the Rexam Agreement, Crown shall not agree to such an amendment without Constar’s consent. 
  
 5. INFRINGEMENT 
  
 5.1. Notice. If either party becomes aware of actual or threatened infringement by a Third Party of the Oxbar Technology in the Licensed Field, it shall promptly notify the other party in writing of such infringement or
threat. 
  
 5.2. Suit By Constar. Constar shall have the right to bring suit in its own name and at its own
expense against any infringement of the Constar Oxbar Patents and the Oxbar Trade Secrets, and to the extent permitted by the Rexam Agreement, Constar shall have the right to bring suit in its own name and at its own expense against any infringement
of the Rexam Oxbar Patents. Crown shall join as a plaintiff in any such suit, if required by law, and shall provide reasonable cooperation at the request of Constar in the prosecution of any such suit, provided that Constar shall reimburse Crown for
Crown’s reasonable expenses. Crown, if permitted by law, may elect to participate in any such suit at its own expense by counsel of its own choosing. Constar shall retain all amounts recovered, whether by judgment, award, settlement or
otherwise, in any suit commenced and maintained to its conclusion by Constar under this Section 5.2. 
  
 6. TRADEMARK LICENSE 
  
 6.1. Grant of License. 
  
 (a) Constar hereby grants to Crown a royalty-free, non-exclusive, worldwide license to use the Marks on and in connection with the
Licensed Products, including, without 

 
 4 

 
limitation, the right to sublicense use of such Marks. For purposes of this Section 6 only, “Licensed Products” shall mean products, other than products manufactured with PET,
that embody one or more claims of an Oxbar Patent, whether or not such Oxbar Patent has expired. 
  
 (b) Crown shall
have the right to develop and use (i) new composite marks incorporating any of the Marks, (ii) new logotypes, designs and trade dress for the Marks and any such composite Marks, and (iii) other new trademarks and service marks for use on and in
connection with the goods and services of the Business, all of the foregoing to be referred to collectively as the “New Marks.” Crown shall notify Constar of all material New Marks from time to time, and each New Mark shall be deemed
approved unless Constar delivers its objection to Crown within thirty (30) days after Crown delivers such notice. Each New Mark that is developed pursuant to this Section 6.1(b) shall be owned by Constar as of the date of its adoption by Crown and,
if registered, registered in Constar’s name, and shall be automatically considered a “Mark” under this Agreement for all purposes.  Exhibit B of this Agreement shall be revised from time to time to include the New Marks.
 
  
 (c) During the term of this Agreement, Constar may create, or acquire through assignment or otherwise,
additional marks relating to the Oxbar Technology (the “Additional New Marks”). Each Additional New Mark shall automatically be considered a “Mark” under this Agreement for all purposes. Exhibit B of this Agreement shall
be revised from time to time to include the Additional New Marks.  
  
 6.2. Quality Control.

  
 (a) Crown shall use the Marks only on or in connection with Licensed Products that meet or exceed reasonable
quality control standards that Constar may establish and communicate in writing to Crown from time to time. In no event shall such standards require a level of quality higher than the general level of quality of products manufactured or sold by
Constar under the marks, unless a higher level of quality would be reasonably required for a particular Licensed Product to comply with governmental regulations or generally recognized industry standards that are applicable to such Licensed Product.

  
 (b) Crown shall furnish to Constar, or its duly authorized representatives or agents, representative examples of
advertising, promotional, packaging, labeling and wrapping materials, and web sites that bear the Marks (“Promotional Materials”) for approval by Constar prior to the use thereof. Such approval shall be deemed granted if written advice to
the contrary is not received by Crown within thirty (30) days from the date such materials are received by Constar or if usage is approved or pre-approved according to procedures and standards established by Constar. Individual instances of
inadvertent and unintentional failure to seek the approval required by this Section 6.2(b) shall not constitute breach of this Agreement provided that such failures are not indicative of a pattern of a general practice of failing to abide by this
Section 6.2(b). Notwithstanding the foregoing, in no event shall Constar object to Promotional Materials that meet or exceed the general level quality of materials used by Crown in connection with goods and services other than the Licensed Products.

  
 (c) Subject to Section 6.2(b), Crown shall be responsible for monitoring the quality of the Licensed Products and
the Promotional Materials, and for reporting any material deficiencies to Constar. Constar may from time to time require Crown to provide reports on such quality control and samples of use of the Marks on Licensed Products or Promotional

 
 5 

 
Materials, and may from time to time retain at Constar’s expense a third party to investigate, evaluate and otherwise monitor the Licensed Products and Promotional Materials to ensure that
the quality control standards set forth herein are being met. 
  
 6.3. Trademark Notices. Crown shall use
reasonable efforts to utilize such symbols or other indicia of trademark ownership as required by law or as Crown reasonably deems appropriate in connection with its use of a Mark. 
  
 6.4. Ownership and Maintenance of Marks; Infringement Claims. 
  
 (a) Crown acknowledges that the ownership of all right, title, and interest in the Marks is and shall remain solely vested in Constar, and Crown agrees that all of its use of the Marks shall inure to
the exclusive benefit of Constar for all purposes. 
  
 (b) Constar shall at its own expense have primary
responsibility for maintaining and defending the validity of the Marks and its ownership of the Marks, for seeking and maintaining such registrations of the Marks as Constar deems advisable, and for taking such steps as Constar deems prudent to
protect the Marks against infringement. 
  
 (c) Crown shall promptly notify Constar of (i) any unauthorized use or
infringement by any third party of any of the Marks which Crown deems material and (ii) any assertion by any third party which Crown deems material that Crown’s or any sublicensee’s use of any of the Marks constitutes trademark, service
mark, trade dress or trade name infringement, unfair competition or any other tortious act. Constar may prosecute or defend any claim or action alleging infringement or unfair competition or any other claim or action involving any of the Marks as it
in its reasonable business judgment deems advisable. Constar may conduct each such prosecution or defense as it deems prudent and may enter into any settlement or compromise of such claims or actions on Constar’s behalf, provided, however, that
if Constar enters into any settlement or compromise which would result in the abandonment of any Mark which is in current use, Constar must notify Crown of the settlement or compromise and provide an opinion of trademark counsel demonstrating the
rationale for that result. 
  
 7. REPRESENTATIONS AND WARRANTIES 
  

	7.1.
	 
	Constar represents and warrants that it has, and will have throughout the term of this Agreement, the right to grant the licenses and sublicenses described
herein. 
 

  

	7.2.
	 
	Each of Crown and Constar represents and warrants to the other that: 
 

  
 (a) it has the requisite corporate authority to enter into and perform this Agreement; 
  
 (b) its execution, delivery, and performance of this Agreement has been duly authorized by all requisite corporate action on its behalf; and 

 
 (c) this Agreement is enforceable against it. 

 
 6 

  
 8. TERMINATION 
  
 8.1. Term. This Agreement shall commence on the Initial Public Offering Date and shall continue until terminated pursuant to
Section 8.2, provided that upon the expiration of each Oxbar Patent, this Agreement shall terminate with respect to such Oxbar Patent. 
  
 8.2. Termination. Either party may terminate this Agreement in the event that the other party materially breaches any applicable provision of this Agreement, subject to a 30-day cure period after notice regarding such
breach. Each party shall provide the other party with prompt notice upon discovery of a default by the other party; provided, that failure to give such notice shall not limit or restrict the ability of a party to terminate this Agreement
subject to the cure period provided in this Section 8.2. 
  
 8.3. Effect of Termination. Termination of this
Agreement pursuant to this Section 8.2, shall not relieve Constar of its obligations under Section 10 of this Agreement (Royalty Sharing), which shall endure until the expiration of the last Oxbar Patent to expire. 
  
 9. SUBLICENSING AND ASSIGNMENT 
  
 9.1. Neither party may assign or delegate its rights or obligations under this Agreement without the other party’s prior written consent, except that (i) Crown may, after giving notice to Constar,
assign or delegate its rights and obligations under this Agreement, in whole or in part (a) to an Affiliate, or (b) to a successor to the relevant part or all Crown’s business or of an Affiliate’s business in connection with a
reorganization, merger, or other acquisition, so long as the assignee of any obligations agrees in writing to assume such obligations; (ii) Constar may, after giving notice to Crown, assign or delegate its rights and obligations under this Agreement
(a) to an Affiliate, or (b) to a successor to all or substantially all of Constar’s business, or to all of Constar’s rights in the Oxbar Technology, in connection with a reorganization, merger, or other acquisition, so long as, in each
such case, the assignee or delegatee of any obligations agrees in writing to assume such obligations; and (iii) Constar may, and hereby gives notice to Crown that it intends to, pledge its rights and obligations under this Agreement to its lenders
as collateral to secure indebtedness outstanding under its senior secured credit facility and all renewals, refundings, refinancings and replacements thereof. 
  
 9.2. Crown may sublicense and further sublicense its rights under this Agreement to Crown’s Affiliates. 
  
 9.3. This Agreement shall be binding upon, and shall inure to the benefit of, the parties hereto and their respective successors and permitted assigns and sublicensees. Nothing in this Agreement,
express or implied, is intended to or shall (a) confer on any person other than the parties hereto and their respective successors or permitted assigns and sublicensees any rights (including third party beneficiary rights), remedies, obligations or
liabilities under or by reason of this Agreement, or (b) constitute the parties hereto as partners or as participants in a joint venture. This Agreement shall not provide third parties with any remedy, claim, liability,
 

 
 7 

 
reimbursement, cause of action or other right in excess of those existing without reference to the terms of this Agreement. 
  
 10. ROYALTY SHARING 
  
 10.1. Amount of Royalty Share. With respect to all Third-Party Royalties collected by Constar or its Affiliates, Constar shall make payments (“Royalty Sharing Payments”) to Crown in the following amounts:

  
 (a) For the first ten million dollars ($10,000,000.00) of Third-Party Royalties received by
Constar and its Affiliates in a given Contract Year, Constar shall pay Crown 41.67% of such Third-Party Royalties, provided that such percentage shall not be applied against any portion of such Third-Party Royalties that are paid or payable by
Constar to Rexam pursuant to the Rexam Agreement; and 
  
 (b) For all Third-Party Royalties received
by Constar and its Affiliates in a given Contract Year above the first ten million dollars ($10,000,000.00), Constar shall pay Crown 50.00% of such Third-Party Royalties, provided that such percentage shall not be applied against any portion of such
Third-Party Royalties that are paid or payable by Constar to Rexam pursuant to the Rexam Agreement. 
  
 10.2.
Terms of Payment. Constar shall pay all payments due Crown under Section 10.1 within sixty (60) days after the end of the relevant Contract Year for royalties received by Constar during such Contract Year. 
  
 10.3. Withholding. All payments by Constar under this Agreement shall be free and clear of any deductions for taxes, assessments or
other charges. If Constar shall be required by the laws of any jurisdiction to deduct or withhold from any payment to Crown any income taxes which may be levied against Crown, Constar may deduct such income taxes, provided that it promptly furnishes
to Crown an original or duplicate tax receipt evidencing the payment of such taxes to the appropriate authority. If (i) Constar fails to provide a receipt to Crown as required by this Section 10.3 or (ii) such tax is not allowed or allowable as a
credit against Crown’s United States federal income taxes, then Constar’s payment shall be increased to an amount equal to the pre-tax payment due divided by a factor equal to one minus the applicable foreign tax rate. The tax shall then
be applied to and deducted from the increased payment. 
  
 10.4. Reports. Constar shall deliver to Crown,
simultaneously with payment pursuant to Section 10.2, a written statement signed by a responsible officer of Constar in such detail as Crown may reasonably require, showing the Third-Party Royalties received during the Contract Year and the
calculation of the payment due. If no payments are due for the Contract Year, the report shall so state, and such report shall be delivered within sixty (60) days after the end of such Contract Year. 
  
 10.5. Records and Audit 
  
 (a) Constar shall maintain, and shall cause its Affiliates to maintain, complete, clear and accurate records sufficient to allow calculation of the payment due for each Contract Year. Such records
shall be maintained for a period of six (6) years after the end of the Contract
 

 
 8 

 
Year to which they relate or, in the event of a dispute between the parties, until such dispute is resolved, whichever date occurs later. 
  

(b) Constar shall permit, and shall cause its Affiliates to permit, Crown or any person designated by Crown to have full access to such records for the purpose of
verifying the amount of payments due Crown. Crown shall be responsible for its own costs and expenses in connection with any audit, except that Constar shall reimburse Crown for all such costs and expenses of any audit which determines that
Constar’s actual payments with respect to two out of any four consecutive Contract Years were less than the amounts payable according to the audit by an amount that equals or exceeds ten percent (10%) of the amounts payable according to the
audit. 
  
 10.6. Interest. Any required payments not made for any reason on or before the date for payment
specified in this Section 10, shall bear interest, calculated from the date such payment is due until the date it is received, at the rate of six percent (6%) annually, prorated on a daily basis, or at the maximum rate allowed by law. 

 
 11.    CONFIDENTIALITY 
  
 11.1. Confidentiality. The parties agree to maintain (a) all information, whether in written, oral, electronic or other form, necessary for or utilized or received
pursuant to any terms of this Agreement (the “Confidential Information”), as secret and confidential and (b) not to disclose the Confidential Information to any third person or party (except for employees, counsel, contractors,
customers, consultants or vendors who have a need to know and are informed of the confidential nature of such information by the disclosing party). Each party shall accept responsibility and be liable any disclosure by any third person of any
Confidential Information disclosed to such third person by such party. The parties will use the same measures to maintain the confidentiality of the Confidential Information of any other party in its possession or control that it uses to maintain
the confidentiality of its own Confidential Information of similar type and importance. Notwithstanding the foregoing, either party or their Affiliates may describe this Agreement in, and include this Agreement with, filings with the U.S. Securities
and Exchange Commission and any related prospectuses, including such filings or prospectuses in connection with any offering of securities. Confidential Information will not include information that (i) is in or enters the public domain without
breach of this Agreement, or (ii) the receiving party lawfully receives from a third party without restriction on disclosure and, to the receiving party’s knowledge, without breach of a nondisclosure obligation. 
  
 11.2. Disclosure to Governmental Agency. Notwithstanding the foregoing, each party shall be permitted to disclose the Confidential
Information and/or any portion thereof (i) to a governmental agency or authority as required in response to a subpoena therefor, (ii) in connection with formal requests for discovery under applicable rules of civil procedure in a legal action before
a court of competent jurisdiction to which such party is a party and (iii) as otherwise required by law; provided, however, that, in any such case, each party shall notify the other party as early as reasonably practicable prior to
disclosure to allow such party to take appropriate measures to preserve the confidentiality of such information at the expense of such party. 

 
 9 

  
 11.3. Ownership of Information. All Confidential Information supplied or
developed by either party will be and remain the sole and exclusive property of the party who supplied or developed it. 
  
 11.4. Return of Confidential Information. Upon the written request of a party which has disclosed information covered by this Section 11 in written, printed or other tangible form, all such readily available information, all
copies thereof, including samples or materials, and all notes or other materials derived from such information shall be returned to the party which disclosed such information. 
  
 12. GOVERNING LAW; DISPUTES; NOTICES. 
  
 12.1. Governing Law. This Agreement shall be governed by and construed in accordance with the substantive laws of the Commonwealth of Pennsylvania, without reference to the conflict of laws principles or doctrines
thereof. 
  
 12.2. Dispute Resolution: Negotiation and Arbitration. 
  
 (a) The parties shall attempt to resolve any dispute arising out of or relating to this Agreement promptly by negotiation in good faith
between executives who have authority to settle the dispute. A party shall give the other party written notice of any dispute not resolved in the ordinary course of business. Within ten (10) business days after delivery of such notice, the party
receiving notice shall submit to the other party a written response thereto. The notice and the response shall include: (i) a statement of each party’s position(s) regarding the matter(s) in dispute and a summary of arguments in support
thereof, and (ii) the name and title of the executive who will represent that party and any other person who will accompany that executive. 
  
 (b) Within ten (10) business days after delivery of the notice, the designated executives shall meet at a mutually acceptable time and place, and thereafter, as often as they reasonably deem necessary,
to attempt to resolve the dispute. All reasonable requests for information made by one party to any other shall be honored in a timely fashion. All negotiations conducted pursuant to this Section 12 (and any of the parties’ submissions in
contemplation hereof) shall be deemed confidential and shall be treated by the parties and their representatives as compromise and settlement negotiations under the United States Federal Rules of Evidence and any similar state rules. 

 
 (c) If the matter in dispute has not been resolved within thirty (30) days after the first meeting of the executives to attempt
to resolve the dispute, either party may submit the dispute to binding arbitration to the Philadelphia, Pennsylvania office of the American Arbitration Association (“AAA”) in accordance with the procedures set forth in the
Commercial Arbitration Rules of the AAA. 
  
 (d) The Commercial Arbitration Rules of the AAA, as modified or revised
by the provisions of this Agreement, shall govern any arbitration proceeding hereunder. The arbitration shall be conducted by three arbitrators selected pursuant to Rule 13 of the Commercial Arbitration Rules, and pre-hearing discovery shall be
permitted if and only to the extent determined by the arbitrator to be necessary in order to effectuate resolution of the matter in dispute. The arbitrator’s decision shall be rendered within thirty (30) days of the conclusion 

 
 10 

 
of any hearing hereunder and the arbitrator’s judgment and award may be entered and enforced in any court of competent jurisdiction. 
  

(e) Resolution of disputes under the procedures of this Section 12 shall be the sole and exclusive means of resolving disputes arising out of or relating to this
Agreement; provided, however, that nothing herein shall preclude the parties from seeking in any court of competent jurisdiction temporary or interim injunctive relief to the extent necessary to preserve the subject matter of the
dispute pending resolution under this Section 12. 
  
 (f) Consent to Jurisdiction. Subject to the provisions
of this Section 12, Constar and Crown hereby agree and consent to be subject to the exclusive jurisdiction of the United States District Court for the Eastern District of Pennsylvania, and in the absence of such federal jurisdiction, the parties
consent to be subject to the exclusive jurisdiction of any state court located in the City of Philadelphia and hereby waive the right to assert the lack of personal or subject matter jurisdiction or improper venue in connection with any such suit,
action or other proceeding. In furtherance of the foregoing, each of the parties (i) waives the defense of inconvenient forum, (ii) agrees not to commence any suit, action or other proceeding arising out of this Agreement or any transactions
contemplated hereby other than in any such court (other than the mandatory submission to arbitration in accordance with this Section 12), and (iii) agrees that a final judgment in any such suit, action or other proceeding shall be conclusive and may
be enforced in other jurisdictions by suit or judgment or in any other manner provided by law. 
  
 12.3.
Notices. All notices hereunder shall be deemed given if in writing and delivered personally or sent by facsimile transmission or by registered or certified mail (return receipt requested) to the parties at the following addresses (or at such
other addresses as shall be specified by like notice: 
  
 if to Crown, to: 
  
 Crown Cork & Seal Company, Inc. 
 One Crown Way 
 Philadelphia, PA 19154 
 Attention: Timothy J. Donahue 
 Facsimile: (215) 676-6011 
  
 if to Constar, to: 
  
 Constar International Inc. 
 One Crown Way 
 Philadelphia, PA 19154 
 Attention: Michael J.
Hoffman 
  
 Any notice given by mail shall be effective when received. Any notice given by facsimile transmission
shall be effective when the appropriate facsimile transmission acknowledgment is received. 

 
 11 

  
 13. MISCELLANEOUS 
  
 13.1. No Waiver. Except as expressly provided in this Agreement: 
  
 (a) No failure or delay in exercising any right, power or remedy under this agreement, and no course of dealing between Constar and Crown, shall operate as
a waiver of any right, power or remedy under this Agreement; 
  
 (b) All rights and remedies granted
by this Agreement are cumulative and not exclusive of any other rights or remedies available to the parties; and 
  
 (c) Any waiver of any provision of this Agreement must be in writing signed by the party against which such waiver is sought to be enforced. 
  
 13.2. Partial Invalidity. If any provision of this Agreement is held invalid or unenforceable in any jurisdiction, such provision shall, as to that jurisdiction, be ineffective to the extent of
such invalidity or unenforceability without in any manner affecting the validity or enforceability of such provision in any other jurisdiction or the remaining provisions of this Agreement in any jurisdiction. 
  
 13.3. Execution in Counterparts. This Agreement and any amendments hereto may be executed in one or more counterparts, each of
which shall be deemed to be an original, but all of which shall be considered one and the same instrument. Delivery of an executed counterpart of a signature page to this Agreement by facsimile shall be as effective as delivery of a manually
executed counterpart of this Agreement. 
  
 13.4. Binding Effect. This Agreement and any rights, interests or
obligations hereunder shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, legal representatives, executors, administrators, successors and permitted assigns. 
  
 13.5. Section Headings; Interpretive Issues. The section and paragraph headings contained in this Agreement are for reference
purposes only and shall not in any way affect the meaning or interpretation of this Agreement. Constar, on the one hand, and Crown, on the other, have participated jointly in the drafting and negotiation of this Agreement. In the event any ambiguity
or question of interpretation or intent arises, this Agreement shall be construed as if drafted jointly by Constar and Crown, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any
provisions of this Agreement. 
  
 13.6. Entire Agreement. This Agreement set forth the entire agreement of the
parties with respect to the subject matter thereof and may not be amended or modified except by written instrument duly executed by the parties. 
  
 13.7. Effectiveness. The terms of this Agreement shall not become effective until the Initial Public Offering Date. 
  
 [Signatures commence on following page] 

 
 12 

 IN WITNESS WHEREOF, the parties have executed this Agreement on the date first written above. 
  
 
	 CROWN CORK & SEAL TECHNOLOGIES CORPORATION
 
	 
	 By:
 	 	 /s/    DANIEL A. ABRAMOWICZ
 

	 Name:
 	 	 Daniel A. Abramowicz
 
	 Title:
 	 	 EVP—Corporate Technologies
 

 
  
 
	 CONSTAR INTERNATIONAL INC.
 
	 
	 By:
 	 	 /s/    JAMES C. COOK
 

	 Name:
 	 	 James C. Cook
 
	 Title:
 	 	 Executive Vice President,
 Chief Financial Officer and Secretary
 

 

 
 13 

  
 EXHIBIT A 
  
 
	 Ref.
 
	  	 Title
 
	  	 Country
 
	  	 Status
 
	  	 Appln No.
 
	  	 Appln Date
 
	  	 Patent No.
 
	  	 Patent Date
 

	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Argentina
 	  	 LG
 	  	 311372
 	  	 07-Aug-88
 	  	 246535
 	  	 31/08/1994
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Australia [PCT]
 	  	 LG
 	  	 19878/88
 	  	 07-Jun-88
 	  	 611181
 	  	 27/09/1991
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Brazil [PCT]
 	  	 LG
 	  	 PI8807141
 	  	 07-Jun-88
 	  	 PI8807141.3
 	  	 26/11/1996
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Canada
 	  	 LG
 	  	 571474
 	  	 07-Jul-88
 	  	 1335912
 	  	 13/06/1995
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Denmark [PCT]
 	  	 LG
 	  	 1436/89
 	  	 07-Jun-88
 	  	 PR173352
 	  	 08-Jul-00
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Finland [PCT]
 	  	 LG
 	  	 891396
 	  	 07-Jun-88
 	  	 101276
 	  	 29/05/1998
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Hong Kong
 	  	 LG
 	  	  	  	  	  	 348/95
 	  	 16/03/1995
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Ireland
 	  	 LG
 	  	 2069/88
 	  	 07-Jul-88
 	  	 60650
 	  	 28/07/1994
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Japan [PCT]
 	  	 LG
 	  	 63-505544
 	  	 07-Jun-88
 	  	 2991437
 	  	 15/10/1999
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Korea, Republic of [PCT]
 	  	 LG
 	  	 700536/89
 	  	 07-Jun-88
 	  	 126141
 	  	 13/10/1997
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Malaysia
 	  	 LG
 	  	 PI8800752
 	  	 07-Jul-88
 	  	 MY103747A
 	  	 30/09/1993
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Mexico
 	  	 LG
 	  	 12397
 	  	 25/07/1988
 	  	 171000
 	  	 24/09/1993
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 New Zealand
 	  	 LG
 	  	 225347
 	  	 07-Aug-88
 	  	 225347
 	  	 03-May-92
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Norway [PCT]
 	  	 LG
 	  	 891238
 	  	 07-Jun-88
 	  	 300423
 	  	 26/05/1997
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Singapore
 	  	 LG
 	  	  	  	  	  	 121/1995
 	  	 30/03/1995
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 South Africa
 	  	 LG
 	  	 88/4895
 	  	 07-Jul-88
 	  	 88/4895
 	  	 26/04/1989
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Taiwan
 	  	 LG
 	  	 77104707
 	  	 07-Sep-88
 	  	 63018
 	  	 19/11/1993
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Thailand
 	  	 LG
 	  	 7170
 	  	 07-Nov-88
 	  	 11123
 	  	 25/10/2001
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Turkey
 	  	 LG
 	  	 35087/88
 	  	 28/07/1988
 	  	 23400
 	  	 29/12/1989
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 U.S.A.
 	  	 LP
 	  	 13985
 	  	 30/10/2001
 	  	  	  	  
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 U.S.A.
 	  	 LP
 	  	 244463
 	  	 02-Apr-99
 	  	  	  	  
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 U.S.A.
 	  	 LG
 	  	 844515
 	  	 18/04/1997
 	  	 5955527
 	  	 21/09/1999
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 U.S.A.
 	  	 LG
 	  	 472841
 	  	 06-Jul-95
 	  	 5639815
 	  	 17/06/1997
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 U.S.A. [PCT]
 	  	 LG
 	  	 340416
 	  	 07-Jun-88
 	  	 5021515
 	  	 06-Apr-91
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 United Kingdom
 	  	 LG
 	  	 8815699.7
 	  	 07-Jan-88
 	  	 2207439
 	  	 02-Dec-92
 
	 4001
 	  	 SUPERBARRIER (BASIC)
 	  	 Venezuela
 	  	 LG
 	  	 1085/88
 	  	 07-Nov-88
 	  	 50944
 	  	 27/07/1988
 
	 4049
 	  	 SUPERBARRIER—PREFORM STORAGE FOR INCREASED LIFETIME
 	  	 South Africa
 	  	 LG
 	  	 89/0728
 	  	 30/01/1989
 	  	 89/0728
 	  	 26/04/1989
 
	 4049
 	  	 SUPERBARRIER—PREFORM STORAGE FOR INCREASED LIFETIME
 	  	 U.S.A. [PCT]
 	  	 LG
 	  	 438441
 	  	 26/01/1989
 	  	 5239016
 	  	 24/08/1993
 
	 4050
 	  	 SUPERBARRIER—HEADSPACE SCAVENGING WALLS
 	  	 Australia [PCT]
 	  	 LG
 	  	 33448/89
 	  	 03-Oct-89
 	  	 618341
 	  	 13/04/1992
 

 

 
 14 

 
	 4050
 	  	 SUPERBARRIER—HEADSPACE-SCAVENGING WALLS
 	  	 Brazil [PCT]
 	  	 LG
 	  	 PI8906385
 	  	 03-Oct-89
 	  	 PI8906385.6
 	  	 13/07/1999
 
	 4050
 	  	 SUPERBARRIER—HEADSPACE-SCAVENGING WALLS
 	  	 Canada
 	  	 LG
 	  	 593411
 	  	 03-Oct-89
 	  	 1324329
 	  	 16/11/1993
 
	 4050
 	  	 SUPERBARRIER—HEADSPACE-SCAVENGING WALLS
 	  	 Denmark [PCT]
 	  	 LG
 	  	 5653/89
 	  	 03-Oct-89
 	  	 173851
 	  	 27/12/2001
 
	 4050
 	  	 SUPERBARRIER—HEADSPACE-SCAVENGING WALLS
 	  	 Japan [PCT]
 	  	 LG
 	  	 1-503600/89
 	  	 03-Oct-89
 	  	 2785405
 	  	 29/05/1998
 
	 4050
 	  	 SUPERBARRIER—HEADSPACE-SCAVENGING WALLS
 	  	 Korea, Republic of [PCT]
 	  	 LG
 	  	 702103.1989
 	  	 03-Oct-89
 	  	 108735
 	  	 12-May-96
 
	 4050
 	  	 SUPERBARRIER—HEADSPACE-SCAVENGING WALLS
 	  	 Norway [PCT]
 	  	 LG
 	  	 894489
 	  	 03-Oct-89
 	  	 176023
 	  	 18/01/1995
 
	 4050
 	  	 SUPERBARRIER—HEADSPACE-SCAVENGING WALLS
 	  	 South Africa
 	  	 LG
 	  	 89/1864
 	  	 03-Oct-89
 	  	 89/1864
 	  	 28/02/1990
 
	 4050
 	  	 SUPERBARRIER—HEADSPACE-SCAVENGING WALLS
 	  	 U.S.A. [PCT]
 	  	 LG
 	  	 435404
 	  	 03-Oct-89
 	  	 5049624
 	  	 17/09/1991
 
	 4050
 	  	 SUPERBARRIER—HEADSPACE-SCAVENGING WALLS
 	  	 United Kingdom
 	  	 LG
 	  	 8905497.7
 	  	 03-Oct-89
 	  	 2216462
 	  	 22/01/1992
 
	 W0160
 	  	 MULTI-TRIP OXBAR BOTTLE
 	  	 European [PCT]
 	  	 LP
 	  	 973065.6
 	  	 11-Jun-00
 	  	  	  	  
	 W0160
 	  	 MULTI-TRIP OXBAR BOTTLE
 	  	 P.C.T.
 	  	 LPA
 	  	 PCT/GB00/04253
 	  	 11-Jun-00
 	  	  	  	  
	 W0160
 	  	 MULTI-TRIP OXBAR BOTTLE
 	  	 United Kingdom
 	  	 LP
 	  	 9926601.7
 	  	 11-Nov-99
 	  	  	  	  

 

 
 15 

 EXHIBIT B 
  
 
	 Country
 
	  	 Mark
 
	  	 Status
 
	  	 Appln. No.
 
	  	 Appln. Date
 
	  	 Regn. No.
 
	  	 Regn. Date
 

	 BX
 	  	 OXBAR
 	  	 LG
 	  	 943720
 	  	 8/5/1999
 	  	 0658550
 	  	 8/5/1999
 
	 CA
 	  	 OXBAR
 	  	 LP
 	  	 1025839
 	  	 8/12/1999
 	  	  	  	  
	 DE
 	  	 OXBAR
 	  	 LG
 	  	 39947897.3/20
 	  	 8/10/1999
 	  	 399 47 897
 	  	 12/17/1999
 
	 DK
 	  	 OXBAR
 	  	 LG
 	  	 VA1999/03330
 	  	 8/17/1999
 	  	 VR2000/01584
 	  	 3/23/2000
 
	 FR
 	  	 OXBAR
 	  	 LG
 	  	 99/807858
 	  	 8/13/1999
 	  	 99/807858
 	  	 8/13/1999
 
	 GB
 	  	 OXBAR
 	  	 LG
 	  	 2189144
 	  	 2/18/1999
 	  	 2189144
 	  	 2/18/1999
 
	 SE
 	  	 OXBAR
 	  	 LG
 	  	 99-05647
 	  	 8/10/1999
 	  	 347007
 	  	 6/21/2001
 
	 US
 	  	 OXBAR
 	  	 LPA
 	  	 75/769688
 	  	 8/6/1999
 	  	  	  	  
	 BX
 	  	 OXBAR
 	  	 LGK
 	  	 734636
 	  	 9/21/1989
 	  	 466862
 	  	 9/21/1989
 
	 DE
 	  	 OXBAR
 	  	 LGK
 	  	 C39603/16Wz
 	  	 9/11/1989
 	  	 1167204
 	  	 9/11/1989
 
	 DK
 	  	 OXBAR
 	  	 LGK
 	  	 6686/89
 	  	 9/12/1989
 	  	 2408-1991
 	  	 4/26/1991
 
	 ES
 	  	 OXBAR
 	  	 LGK
 	  	 1519854
 	  	 9/18/1989
 	  	 1519854
 	  	  
	 FR
 	  	 OXBAR
 	  	 LGK
 	  	 154563
 	  	 9/14/1989
 	  	 1550894
 	  	 9/14/1989
 
	 IT
 	  	 OXBAR
 	  	 LGK
 	  	 12645C
 	  	 9/14/1989
 	  	 565484
 	  	 9/14/1989
 
	 SE
 	  	 OXBAR
 	  	 LG
 	  	 89-8559
 	  	 9/12/1989
 	  	 226169
 	  	 8/30/1991
 
	 PH
 	  	 OXBAR
 	  	  	  	  	  	 10/9/2002
 	  	  	  	  
	 PH
 	  	 OXBAR
 	  	  	  	  	  	 10/9/2002
 	  	  	  	  
	 PH
 	  	 OXBAR
 	  	  	  	  	  	 10/9/2002
 	  	  	  	  

 

 
 16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}]]